JH, B., YH, J., SJ, Y., MR, W., Y, Y., HX, W., & LM, W. (2022). Investigation of the inhibition effect of 1,2,3,4,6-pentagalloyl-β-D-glucose on gastric cancer cells based on a network pharmacology approach and experimental validation. Frontiers in oncology, 12, 934958. https://doi.org/10.3389/fonc.2022.934958
Chicago Style (17th ed.) CitationJH, Bi, Jiang YH, Ye SJ, Wu MR, Yi Y, Wang HX, and Wang LM. "Investigation of the Inhibition Effect of 1,2,3,4,6-pentagalloyl-β-D-glucose on Gastric Cancer Cells Based on a Network Pharmacology Approach and Experimental Validation." Frontiers in Oncology 12 (2022): 934958. https://doi.org/10.3389/fonc.2022.934958.
MLA (9th ed.) CitationJH, Bi, et al. "Investigation of the Inhibition Effect of 1,2,3,4,6-pentagalloyl-β-D-glucose on Gastric Cancer Cells Based on a Network Pharmacology Approach and Experimental Validation." Frontiers in Oncology, vol. 12, 2022, p. 934958, https://doi.org/10.3389/fonc.2022.934958.